Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dental organic matrix is a complex assembly of proteins, proteoglycans, and lipids that orchestrates the biomineralization and structural integrity of enamel and dentin (George & Veis, 2008). In enamel, the matrix is transient and primarily composed of amelogenins (90%), enamelins, and ameloblastins, which facilitate the organized growth of hydroxyapatite crystals before being largely removed during maturation (Gil-Bona & Bidlack, 2020). Recent studies have also identified the presence of keratins, such as KRT75, which contribute to enamel's mechanical properties and resistance to caries (Duverger et al., 2014). Dentin's organic matrix is permanent and consists of approximately 90% Type I collagen, providing a scaffold for mineral deposition regulated by non-collagenous proteins like dentin sialophosphoprotein (DSPP) and dentin matrix protein 1 (DMP1) (George & Veis, 2008). Pathological degradation of these molecules by host-derived matrix metalloproteinases (MMPs) is a key factor in dental caries and the failure of adhesive restorations (Tjäderhane et al., 2013). Therapeutic strategies include the use of enamel matrix derivatives for periodontal regeneration and MMP inhibitors like chlorhexidine to preserve the dentin-adhesive interface (Miron et al., 2016; Tjäderhane et al., 2013).
Therapeutic agents interact with the dental organic matrix through several mechanisms: matrix metalloproteinase (MMP) inhibition to prevent the degradation of collagen fibrils (e.g., chlorhexidine, doxycycline), biomimetic mineralization where protein analogs or peptides nucleate hydroxyapatite crystals (e.g., enamel matrix derivative, P11-4), and chemical cross-linking to stabilize the collagen scaffold and improve the durability of dental bonds (e.g., glutaraldehyde, carbodiimide) (Tjäderhane et al., 2013; Miron et al., 2016).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dental organic matrix.